SUBSEQUENT EVENTS (Details Narrative) - USD ($) |
1 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 04, 2022 |
Feb. 15, 2022 |
Jan. 31, 2022 |
Aug. 31, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Jul. 29, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Dec. 31, 2019 |
|
| Common stock, par value | $ 0.00001 | $ 0.00001 | $ 0.00001 | |||||||||||
| Stockholders equity | $ 1,356,578 | $ 4,617,295 | $ 3,770,173 | $ 8,679,158 | $ 1,804,533 | $ 2,887,578 | $ 5,786,977 | $ 8,201,624 | $ 4,140,217 | |||||
| Common stock issued | 8,398,708 | 8,166,457 | 8,093,199 | |||||||||||
| Proceeds from warrant exercises | $ 875 | 15,001 | $ 15,001 | $ 37,606 | ||||||||||
| Promissory notes issued | 500,000 | |||||||||||||
| Debt instrument principal amount | $ 630,000 | |||||||||||||
| Exchange Health LLC [Member] | ||||||||||||||
| Interest basis spread | 2.00% | |||||||||||||
| Interest rate | 8.25% | |||||||||||||
| Debt instrument principal amount | $ 166,666.67 | |||||||||||||
| Debt instrument installment amount | $ 41,666.67 | |||||||||||||
| S O S Rx L L C [Member] | ||||||||||||||
| Equity method investment ownership percentage | 51.00% | |||||||||||||
| Exchange Health LLC [Member] | ||||||||||||||
| Equity method investment ownership percentage | 49.00% | |||||||||||||
| S O S Rx L L C [Member] | ||||||||||||||
| Agreed cash payment | $ 325,000 | |||||||||||||
| Promissory notes issued | 500,000 | |||||||||||||
| Earn out payment | $ 400,000 | |||||||||||||
| Minimum [Member] | The Nasday Stock Market L L C [Member] | ||||||||||||||
| Stockholders equity | $ 2,500,000 | |||||||||||||
| Warrant [Member] | ||||||||||||||
| Warrants exercise price | $ 3.00 | |||||||||||||
| Common stock issued | 5,000 | |||||||||||||
| Proceeds from warrant exercises | $ 15,000 | $ 875 | $ 15,000 | |||||||||||
| Subsequent Event [Member] | ||||||||||||||
| Common Stock Issued from Offering, Shares | 920,000 | |||||||||||||
| Common stock, par value | $ 0.00001 | |||||||||||||
| Warrants price per share | $ 1.15 | |||||||||||||
| Percentage of common stock outstanding | 4.99% | |||||||||||||
| Warrants percentage description | the Company subject to the terms of such warrants, provided that such percentage may in no event exceed 9.99%, and provided further that the Purchaser has elected to increase the ownership limitation to 9.99% in connection with the initial issuance of the Pre-Funded Warrants | |||||||||||||
| Percentage of issued and outstanding common stock | 19.99% | |||||||||||||
| Proceeds from issuance of warrants | $ 1,750,000 | |||||||||||||
| Proceeds from company offering | $ 1,500,000 | |||||||||||||
| Milestone description | The Earn Out Payments require the Company to pay (a) $25,000 to Exchange Health if total revenue for SOSRx are over $0.7 million, and $25,000 to Exchange Health if total EBITDA is over $0.5 million, for fiscal year ending 2022; (b) $87,500 to Exchange Health if total revenue for SOSRx is over $3.3 million, and $87,500 to Exchange Health if total EBITDA is over $2.95 million, for fiscal year ending 2023; and (c) $87,500 to Exchange Health if total revenue for SOSRx is over $5.7 million, and $87,500 to Exchange Health if total EBITDA is over $4.9 million, for fiscal year ending 2024, provided that certain amounts will be payable in the event at least 95% of such milestones are met, and such payments will be grossed up or down by up to 5% of such amounts, if such milestone amounts are between 95% and 105% of the required thresholds. | |||||||||||||
| Debt instrument delinquent payment description | In the event that the Company is delinquent to pay when due (whether at maturity, by reason of acceleration or otherwise) any principal of or interest on the Promissory Note, then if such payment is not made within fifteen days of the due date, then Exchange Health may declare an additional interest fee of 2% of the delinquent amount to be due. If the delinquency is thirty days or more late from the due date, then Exchange Health may declare another additional interest fee of 3%, to make a total of 5%, for the delinquent payment. | |||||||||||||
| Subsequent Event [Member] | Exchange Health LLC [Member] | ||||||||||||||
| Interest basis spread | 2.00% | |||||||||||||
| Interest rate | 5.25% | |||||||||||||
| Debt instrument principal amount | $ 166,666.67 | |||||||||||||
| Debt instrument installment amount | $ 41,666.67 | |||||||||||||
| Subsequent Event [Member] | S O S Rx L L C [Member] | ||||||||||||||
| Equity method investment ownership percentage | 51.00% | |||||||||||||
| Subsequent Event [Member] | Exchange Health LLC [Member] | ||||||||||||||
| Equity method investment ownership percentage | 49.00% | |||||||||||||
| Subsequent Event [Member] | S O S Rx L L C [Member] | ||||||||||||||
| Agreed cash payment | $ 325,000 | |||||||||||||
| Promissory notes issued | 500,000 | |||||||||||||
| Earn out payment | 400,000 | |||||||||||||
| Contribution of property | 792,500 | |||||||||||||
| Cash payments | $ 275,000 | |||||||||||||
| Subsequent Event [Member] | Placement Agent Agreement [Member] | ||||||||||||||
| Percentage of cash fee | 7.00% | |||||||||||||
| Warrants and reimbursed expense | $ 35,000 | |||||||||||||
| Subsequent Event [Member] | Operating Agreement [Member] | Minimum [Member] | S O S Rx L L C [Member] | ||||||||||||||
| Equity method investment ownership percentage | 25.00% | |||||||||||||
| Subsequent Event [Member] | Operating Agreement [Member] | Maximum [Member] | S O S Rx L L C [Member] | ||||||||||||||
| Equity method investment ownership percentage | 50.00% | |||||||||||||
| Subsequent Event [Member] | Asset Contribution Agreement [Member] | Exchang Health L L C [Member] | ||||||||||||||
| Equity method investment ownership percentage | 49.00% | |||||||||||||
| Subsequent Event [Member] | Private Placement Warrants [Member] | ||||||||||||||
| Warrants issued to purchase common stock | 2,663,045 | |||||||||||||
| Subsequent Event [Member] | Pre Funded Warrants [Member] | ||||||||||||||
| Warrants issued to purchase common stock | 601,740 | |||||||||||||
| Warrants exercise price | $ 1.14999 | |||||||||||||
| Subsequent Event [Member] | Warrant [Member] | ||||||||||||||
| Warrants issued to purchase common stock | 14,584 | |||||||||||||
| Warrants exercise price | $ 0.06 | |||||||||||||
| Common stock issued | 14,584 | |||||||||||||
| Proceeds from warrant exercises | $ 875 | |||||||||||||